Pediatric Soft Tissue Sarcomas

Surgical Clinics of North America - Tập 88 - Trang 615-627 - 2008
David M. Loeb1,2, Katherine Thornton2,3, Ori Shokek2,4
1Oncology and Pediatrics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Bunting-Blaustein Cancer Research Building, Room 2M51, 1650 Orleans Street, Baltimore, MD 21231, USA
2Musculoskeletal Tumor Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Bunting-Blaustein Cancer Research Building, Room 2M51, 1650 Orleans Street, Baltimore, MD 21231, USA
3Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Bunting-Blaustein Cancer Research Building, Room 1M88, 1650 Orleans Street, Baltimore, MD 21231, USA
4Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Weinberg 1440, 401 North Broadway, Baltimore, MD 21231, USA

Tài liệu tham khảo

Gurney, 1999 Malkin, 1990, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, 250, 1233, 10.1126/science.1978757 Pizzo, 2002 Yang, 1995, Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects, Genet Epidemiol, 12, 467, 10.1002/gepi.1370120504 McDowell, 2003, Update on childhood rhabdomyosarcoma, Arch Dis Child, 88, 354, 10.1136/adc.88.4.354 Seale, 2000, Pax7 is required for the specification of myogenic satellite cells, Cell, 102, 777, 10.1016/S0092-8674(00)00066-0 Lam, 1999, The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain, Mol Cell Biol, 19, 594, 10.1128/MCB.19.1.594 Klem, 2007, PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools, J Pediatr Hematol Oncol, 29, 9, 10.1097/MPH.0b013e3180307693 Meza, 2006, Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group, J Clin Oncol, 24, 3844, 10.1200/JCO.2005.05.3801 Neville, 2000, Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997), J Pediatr Surg, 35, 317, 10.1016/S0022-3468(00)90031-9 McMulkin, 2003, Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma, Pediatr Surg Int, 19, 453, 10.1007/s00383-003-0956-y Godbule, 2006, Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications, J Urol, 176, 1751, 10.1016/j.juro.2006.03.117 Wolden, 1999, Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III, J Clin Oncol, 17, 3468, 10.1200/JCO.1999.17.11.3468 Smith, 2001, Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group, J Clin Oncol, 19, 4058, 10.1200/JCO.2001.19.20.4058 Donaldson, 2001, Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG, Int J Radiat Oncol Biol Phys, 51, 718, 10.1016/S0360-3016(01)01709-6 Donaldson, 2005, Rhabdomyosarcoma: many similarities, a few philosophical differences, J Clin Oncol, 23, 2586, 10.1200/JCO.2005.11.909 Stevens, 2005, Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology–SIOP Malignant Mesenchymal Tumor 89, J Clin Oncol, 23, 2618, 10.1200/JCO.2005.08.130 McArthur, 2005, Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225, J Clin Oncol, 23, 866, 10.1200/JCO.2005.07.088 Peng, 2006, Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study, Clin Nucl Med, 31, 394, 10.1097/01.rlu.0000222954.38724.be Volker, 2007, Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial, J Clin Oncol, 25, 5435, 10.1200/JCO.2007.12.2473 Ball, 1990, Diagnosis of soft tissue tumours by Tru-Cut biopsy, Br J Surg, 77, 756, 10.1002/bjs.1800770713 Barth, 1992, A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses, Surgery, 112, 536 Heslin, 1997, Core needle biopsy for diagnosis of extremity soft tissue sarcoma, Ann Surg Oncol, 4, 425, 10.1007/BF02305557 Clark, 2005, Soft-tissue sarcomas in adults, N Engl J Med, 353, 701, 10.1056/NEJMra041866 Clark, 2003, Amputation for soft-tissue sarcoma, Lancet Oncol, 4, 335, 10.1016/S1470-2045(03)01113-6 Spiro, 1995, Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience, Cancer Invest, 13, 86, 10.3109/07357909509024899 Kattan, 2002, Postoperative nomogram for 12-year sarcoma-specific death, J Clin Oncol, 20, 791, 10.1200/JCO.20.3.791 Eilber, 2004, Validation of the postoperative nomogram for 12-year sarcoma-specific mortality, Cancer, 101, 2270, 10.1002/cncr.20570 Ferrari, 2007, Adult-type soft tissue sarcomas in paediatric age: A nomogram-based prognostic comparison with adult sarcoma, Eur J Cancer, 43, 2691, 10.1016/j.ejca.2007.09.012 Spunt, 2002, Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma, J Clin Oncol, 20, 3225, 10.1200/JCO.2002.06.066 Edmonson, 1993, Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas, J Clin Oncol, 11, 1269, 10.1200/JCO.1993.11.7.1269 Verweij, 1992, Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective, Ann Oncol, 3, S75, 10.1093/annonc/3.suppl_2.S75 O'Sullivan, 2002, Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial, Lancet, 359, 2235, 10.1016/S0140-6736(02)09292-9 Davis, 2002, Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma, J Clin Oncol, 20, 4472, 10.1200/JCO.2002.03.084 Davis, 2005, Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma, Radiother Oncol, 75, 48, 10.1016/j.radonc.2004.12.020